BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29271991)

  • 1. Sensitization of TRAIL-resistant cervical cancer cells through combination of TRAIL and fucoxanthin treatments.
    Ye GL; Du DL; Jin LJ; Wang LL
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5594-5601. PubMed ID: 29271991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-κB Signaling Pathway.
    Jin Y; Qiu S; Shao N; Zheng J
    Med Sci Monit; 2018 Jan; 24():11-18. PubMed ID: 29291370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucoxanthin induces apoptosis in human cervical cancer cell line HeLa via PI3K/Akt pathway.
    Ye G; Lu Q; Zhao W; Du D; Jin L; Liu Y
    Tumour Biol; 2014 Nov; 35(11):11261-7. PubMed ID: 25113250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma.
    Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S
    Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of autophagy in fucoxanthin-induced cytotoxicity to human epithelial cervical cancer HeLa cells.
    Hou LL; Gao C; Chen L; Hu GQ; Xie SQ
    Acta Pharmacol Sin; 2013 Nov; 34(11):1403-10. PubMed ID: 23974517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 activity regulates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cervical cancer cells.
    Nakamura H; Taguchi A; Kawana K; Kawata A; Yoshida M; Fujimoto A; Ogishima J; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Eguchi S; Mori-Uchino M; Yamashita A; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Osuga Y; Fujii T
    Int J Oncol; 2016 Nov; 49(5):2155-2162. PubMed ID: 27599897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
    Zhu K; Fang W; Chen Y; Lin S; Chen X
    Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
    Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH
    Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway.
    Hu L; Wang Y; Chen Z; Fu L; Wang S; Zhang X; Zhang P; Lu X; Jie H; Li M; Wang Y; Liu Z
    Oxid Med Cell Longev; 2019; 2019():9675450. PubMed ID: 31019655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
    Rychahou PG; Murillo CA; Evers BM
    Surgery; 2005 Aug; 138(2):391-7. PubMed ID: 16153452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoinositide-3-kinase inhibition enhances radiosensitization of cervical cancer in vivo.
    Liu Y; Cui B; Qiao Y; Zhang Y; Tian Y; Jiang J; Ma D; Kong B
    Int J Gynecol Cancer; 2011 Jan; 21(1):100-5. PubMed ID: 21330835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.
    Li L; Wen XZ; Bu ZD; Cheng XJ; Xing XF; Wang XH; Zhang LH; Guo T; Du H; Hu Y; Fan B; Ji JF
    Oncol Rep; 2016 May; 35(5):3009-17. PubMed ID: 26986870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
    Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
    Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chamaejasmine induces apoptosis in HeLa cells through the PI3K/Akt signaling pathway.
    Qian S; Li M
    Anticancer Drugs; 2017 Jan; 28(1):40-50. PubMed ID: 27557139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer.
    Zhang W; Zhou J; Zhu X; Yuan H
    Gene; 2017 Sep; 627():420-427. PubMed ID: 28669929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways.
    Dong P; Hao F; Dai S; Tian L
    J Recept Signal Transduct Res; 2018 Feb; 38(1):83-88. PubMed ID: 29369007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
    Thanaketpaisarn O; Waiwut P; Sakurai H; Saiki I
    Int J Oncol; 2011 Jul; 39(1):279-85. PubMed ID: 21537836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
    Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP
    Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.